Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area proteases calpains'

Search results for: 'research area proteases calpains'

Items 1-10 of 342

Page
per page
  1. Calpain Inhibitor I, ALLN
    A2602 Calpain Inhibitor I, ALLN
     2 Citation
    Target: Cathepsins|Calpains
    Summary: Calpain I/II/ B/L inhibitor
  2. Calpain Inhibitor II, ALLM
    A2603 Calpain Inhibitor II, ALLM
     2 Citation
    Summary: Calpain inhibitor
      insoluble in H2O; ≥14.85 mg/mL
  3. Calpain Inhibitor XII
    C5347 Calpain Inhibitor XII
    Summary: reversible and selective inhibitor of calpain I
      ≤16 mg/mL
  4. MDL 28170
    A4412 MDL 28170
    Target: Cathepsins|Calpains
    Summary: Calpain and cathepsin B inhibitor, selective
      insoluble in H2O; ≥16.75 mg/mL
  5. Calpeptin
    A4411 Calpeptin
    Summary: Ca2+-dependent protease,calpain inhibitor
      insoluble in H2O; ≥87.6 mg/mL
  6. Calpain Activity Fluorometric Assay Kit
    K2062 Calpain Activity Fluorometric Assay Kit
    Summary: Exclusively detects activated calpain
  7. Acetyl-Calpastatin (184-210) (human)
    A4410 Acetyl-Calpastatin (184-210) (human)
    Summary: Calpain I/II inhibitor
      Soluble to 5 mg/mL
  8. TEV Protease
    K1098 TEV Protease
    Summary: TEV Protease (His-tag), Cysteine protease
  9. SUMO Protease
    K1103 SUMO Protease
    Summary: SUMO Protease, Ulp
  10. Z-FA-FMK
    A8170 Z-FA-FMK
    Target: cysteine protease
    Summary: Cysteine proteases inhibitor
      insoluble in H2O; ≥13.45 mg/mL

Items 1-10 of 342

Page
per page
Shop By
Shopping Options
Category
  1. Signaling Pathways 187item
  2. Natural Products 1 item
  3. Other Products 1 item
  4. Protein 12item
  5. Kits 49item
  6. Screening Library 31item
  7. Peptides 2item
  8. Probes & Dyes 3item
  9. Cell Biology 12item
  10. Peptides & Proteins 50item
  11. Protein & Immunology 19item
Specificity
  1. Selective 63item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 11item
  2. Irreversible 10item
Target
  1. Caspases 1 item
  2. Proteasome 10item
  3. Cathepsins 11item
  4. MMP 3item
  5. Thymidylate Synthase 1 item
  6. Deubiquitinating enzymes (DUBs) 2item
  7. Trk Receptors 1 item
  8. Aminopeptidases 3item
  9. EGFR 1 item
  10. HSP90 5item
  11. Topoisomerases 1 item
  12. Renin 1 item
  13. HIV proteases 1 item
  14. Pepsins 1 item
  15. Serine Proteases 2item
  16. Calpains 6item
  17. Ubiquitin-specific proteases 1 item
  18. HCV Proteases 2item
  19. Trypsins 1 item
  20. Trypsin 1 item
  21. Chymotrypsin 1 item
  22. Kallikrein 1 item
  23. Trypsinogen 1 item
  24. HIV-1 gp120 1 item
  25. Fatty-acid-binding proteins (FABPs) 1 item
  26. HIV Integrases 1 item
  27. 20S proteasomal chymotrypsin 1 item
  28. Geranylgeranyltransferase I 1 item
  29. Farnesyltransferase 1 item
  30. Urokinases 1 item
  31. Histamine H1 Receptors 1 item
  32. IL Receptors 1 item
  33. CCL2 1 item
  34. Papains 1 item
  35. DPP-4 4item
  36. ADAMs 1 item
  37. Trypsin-like protease 1 item
  38. PAR 2item
  39. cysteine protease 2item
  40. Elastases 1 item
  41. integrase 1 item
  42. HCV NS3-4A protease 1 item
  43. TRPC channel 1 item
Reported Experiments
  1. Animal Experiments 76item
  2. Cell Experiments 64item
Related Disease
  1. Acute Lung Injury 1 item
  2. Breast Cancer 8item
  3. Cancer 31item
  4. Colon Cancer 3item
  5. Colon Carcinoma 1 item
  6. Colorectal Cancer 2item
  7. Diabetes 4item
  8. Glioma 1 item
  9. HCV 1 item
  10. Hepatitis C 2item
  11. HIV 4item
  12. HIV Infections 1 item
  13. Inflammatory Diseases 1 item
  14. Leukemia 1 item
  15. Lung Cancer 1 item
  16. Lymphoma 1 item
  17. Mantle Cell Lymphoma 1 item
  18. Melanoma 3item
  19. Multiple Myeloma 4item
  20. Myeloma 2item
  21. Neuroblastoma 1 item
  22. Non-small Cell Lung Cancer 3item
  23. Osteoporosis 1 item
  24. Ovarian Cancer 3item
  25. Pancreatic Cancer 2item
  26. Prostate Cancer 2item
  27. Psoriasis 1 item
  28. Renal Cell Carcinoma 1 item
  29. Rheumatoid Arthritis 2item
  30. Squamous Cell Carcinoma 1 item
  31. Type 2 Diabetes 1 item